Intraoperative Analysis of the Central Retina in ERF
1 other identifier
interventional
60
1 country
1
Brief Summary
Changes in the retinal anatomy that occur in epiretinal fibrosis have not been sufficiently studied. It is possible that epiretinal fibrosis leads not only to traction dislocation of the macula, but also to ILM anatomical disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2019
CompletedFirst Submitted
Initial submission to the registry
December 6, 2020
CompletedFirst Posted
Study publicly available on registry
March 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedMarch 17, 2021
March 1, 2021
3 years
December 6, 2020
March 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
ILM integrity
Visual intraoperative assessment of the ILM integrity
intraoperative
Length and localization of the ILM dialysis
Length (in degrees) and localization of the ILM dyalisis
intraoperative
ILM displacement
ILM displacement direction during the formation of detachment and divulsion.
intraoperative
Occurence of ILM dyalisis
Determination of the ratio of patients with ILM dialysis to the total number of patients with ERF
intraoperative
Study Arms (1)
epiretinal membrane group
OTHERPatient with epiretinal fibrosis confirmed by OCT with BCVA\< 0,6 and complaints of metamorphopsies
Interventions
ERM and ILM staining is performed after vitrectomy. After that we evaluate the condition of macular zone and make a decision to remove the ERM and the need to remove the ILM
Eligibility Criteria
You may qualify if:
- BCVA \< 0,6;
You may not qualify if:
- secondary ERM, glaucoma, diabetic retinopathy, high myopia, BCVA\>0,6
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The S.N. Fyodorov Eye Microsurgery State Institutionlead
- Makarenko Irina Romanovnacollaborator
- Zgoba Mariana Igorevnacollaborator
Study Sites (1)
S.N. Fedorov Nmrc "Mntk "Eye Microsurgery"
Moscow, 127486, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pavel V Lyskin, PhD
The S.N. Fyodorov Eye Microsurgery State Institution
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, ophthalmosurgeon
Study Record Dates
First Submitted
December 6, 2020
First Posted
March 17, 2021
Study Start
January 15, 2019
Primary Completion
January 1, 2022
Study Completion
December 1, 2022
Last Updated
March 17, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share